Chimerix Stock Analysis

CMRX Stock  USD 1.01  0.02  2.02%   
Chimerix is undervalued with Real Value of 2.47 and Target Price of 7.0. The main objective of Chimerix stock analysis is to determine its intrinsic value, which is an estimate of what Chimerix is worth, separate from its market price. There are two main types of Chimerix's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Chimerix's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Chimerix's stock to identify patterns and trends that may indicate its future price movements.
The Chimerix stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Chimerix is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Chimerix Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Chimerix's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.

Chimerix Stock Analysis Notes

About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. Chimerix recorded a loss per share of 0.93. The entity had not issued any dividends in recent years. Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on Chimerix please contact Michael MBA at 919-806-1074 or go to https://www.chimerix.com.

Chimerix Quarterly Total Revenue

4,000

Chimerix Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Chimerix's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Chimerix or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Chimerix has some characteristics of a very speculative penny stock
Chimerix had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 324 K. Net Loss for the year was (82.09 M) with loss before overhead, payroll, taxes, and interest of (36.49 M).
Chimerix currently holds about 42.79 M in cash with (69.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49.
Chimerix has a poor financial position based on the latest SEC disclosures
Latest headline from investorplace.com: 7 Struggling Semiconductor Stocks to Sell in March

Chimerix Upcoming and Recent Events

Earnings reports are used by Chimerix to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chimerix previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Chimerix Largest EPS Surprises

Earnings surprises can significantly impact Chimerix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-08-05
2021-06-30-0.19-0.21-0.0210 
2020-05-07
2020-03-31-0.15-0.17-0.0213 
2023-08-03
2023-06-30-0.24-0.210.0312 
View All Earnings Estimates

Chimerix Thematic Classifications

In addition to having Chimerix stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Biotech Idea
Biotech
Biotechnology and pharmaceuticals production and services

Chimerix Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Chimerix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chimerix backward and forwards among themselves. Chimerix's institutional investor refers to the entity that pools money to purchase Chimerix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bridgeway Capital Management, Llc2023-12-31
M
Geode Capital Management, Llc2023-12-31
912.8 K
Barclays Plc2023-12-31
891.7 K
Northern Trust Corp2023-12-31
690.3 K
Tejara Capital Ltd2023-12-31
550.1 K
Yakira Capital Management, Inc.2023-12-31
508.4 K
Assenagon Asset Management Sa2023-12-31
499.4 K
Bank Of New York Mellon Corp2023-12-31
425.5 K
Adage Capital Partners Gp Llc2023-12-31
400 K
Ra Capital Management, Llc2023-12-31
8.8 M
Monaco Asset Management2023-12-31
4.4 M
Note, although Chimerix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chimerix Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 88.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chimerix's market, we take the total number of its shares issued and multiply it by Chimerix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Chimerix Profitablity

Chimerix's profitability indicators refer to fundamental financial ratios that showcase Chimerix's ability to generate income relative to its revenue or operating costs. If, let's say, Chimerix is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Chimerix's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Chimerix's profitability requires more research than a typical breakdown of Chimerix's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2024
Return On Capital Employed(0.48)(0.50)
Return On Assets(0.39)(0.41)
Return On Equity(0.43)(0.45)

Management Efficiency

Chimerix has return on total asset (ROA) of (0.2364) % which means that it has lost $0.2364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.365) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.5 in 2024. Return On Assets is likely to drop to -0.41 in 2024. At this time, Chimerix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 421.1 K in 2024, whereas Total Assets are likely to drop slightly above 197 M in 2024.
Last ReportedProjected for 2024
Price Book Value Ratio 0.44  0.42 
Enterprise Value Multiple(0.64)(0.67)
Price Fair Value 0.44  0.42 
The analysis of Chimerix's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Chimerix's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Chimerix Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.158

Technical Drivers

As of the 28th of March, Chimerix shows the Downside Deviation of 3.64, mean deviation of 2.33, and Risk Adjusted Performance of 0.0404. Chimerix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Chimerix, which can be compared to its rivals. Please confirm Chimerix semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Chimerix is priced correctly, providing market reflects its regular price of 1.01 per share. Given that Chimerix is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Chimerix Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Chimerix middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Chimerix. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Chimerix Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chimerix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Kozin Marc D over a week ago
Insider Trading
 
Timothy Wollaeger over six months ago
Chimerix exotic insider transaction detected
 
Vakiener Victoria over six months ago
Acquisition by Vakiener Victoria of 60000 shares of Chimerix subject to Rule 16b-3

Chimerix Predictive Daily Indicators

Chimerix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chimerix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Chimerix Forecast Models

Chimerix's time-series forecasting models are one of many Chimerix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chimerix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Chimerix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Chimerix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chimerix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Chimerix. By using and applying Chimerix Stock analysis, traders can create a robust methodology for identifying Chimerix entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(253.38)(240.71)
Operating Profit Margin(287.24)(272.88)
Net Loss(253.38)(240.71)
Gross Profit Margin 1.00  1.05 

Current Chimerix Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chimerix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chimerix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.0Strong Buy6Odds
Chimerix current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Chimerix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Chimerix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Chimerix, talking to its executives and customers, or listening to Chimerix conference calls.
Chimerix Analyst Advice Details

Chimerix Stock Analysis Indicators

Chimerix stock analysis indicators help investors evaluate how Chimerix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Chimerix shares will generate the highest return on investment. By understating and applying Chimerix stock analysis, traders can identify Chimerix position entry and exit signals to maximize returns.
Begin Period Cash Flow25.8 M
Long Term Debt125 K
Common Stock Shares Outstanding88.6 M
Total Stockholder Equity193 M
Tax Provision-117 K
Property Plant And Equipment Net1.7 M
Cash And Short Term Investments182.8 M
Cash27.7 M
Accounts Payable2.9 M
Net Debt-25.5 M
50 Day M A1.0538
Total Current Liabilities18.4 M
Other Operating Expenses93.4 M
Non Current Assets Total23.8 M
Forward Price Earnings1.2136
Non Currrent Assets Other401 K
Stock Based Compensation17.5 M
When determining whether Chimerix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chimerix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chimerix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chimerix Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Chimerix Stock analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Chimerix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chimerix. If investors know Chimerix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chimerix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.93)
Revenue Per Share
0.004
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.24)
Return On Equity
(0.36)
The market value of Chimerix is measured differently than its book value, which is the value of Chimerix that is recorded on the company's balance sheet. Investors also form their own opinion of Chimerix's value that differs from its market value or its book value, called intrinsic value, which is Chimerix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chimerix's market value can be influenced by many factors that don't directly affect Chimerix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chimerix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chimerix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chimerix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.